atai Life Sciences Experiences First Quarter 2022 Monetary Outcomes and Enterprise Replace

– Robust execution throughout atai’s three strategic pillars: speedy appearing pharmacological intervention, ongoing digital help and biomarker-driven precision psychological well being – Key milestones embrace first topic dosed in Part…

MindMed Reviews First Quarter 2022 Monetary Outcomes and Enterprise Highlights

– Superior scientific applications for 3 lead drug candidates – – Strengthened management workforce with the appointment of Francois Lilienthal, MD as Chief Industrial Officer – – Money runway by…

Sonnet BioTherapeutics Gives Fiscal 12 months 2022 Second Quarter Enterprise and Earnings Replace

IND for SON-1010 cleared by FDA with first affected person dosed in trial for superior stable tumors SON-080 on monitor to start scientific research by mid-2022 Preclinical…

LTC Experiences 2022 First Quarter Outcomes and Discusses Latest Actions

WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties, Inc. (NYSE: LTC) (“LTC” or the “Firm”), an actual property funding belief that primarily invests in seniors housing and well being care properties, at the…